Status:
UNKNOWN
The Effects of a Regenerative Mitochondrial Medication on Physiological Parameters in Case of Diabetes Mellitus Type II
Lead Sponsor:
Center for Integrative Medicine, Germany
Conditions:
Diabetes Mellitus, Type II
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
Brief Summary
A treatment with the concept of mitochondrial medication developed by Dr Heinrich Kremer can demonstrably improve and successfully treat actual parameters of Diabetes Mellitus II as well as its risk f...
Eligibility Criteria
Inclusion
- men and women between the ages of 18 and 60
- recently diagnosed Diabetes Type II (within the last 12 months)
Exclusion
- no orally-taken medication up to present
- no insulin therapy
- no diseases resulting from diabetes like Nephropathy, Neuropathy, Angiopathy or Retinopathy
- fasting blood sugar values in the morning under 200mmol
- sufficient production of insulin
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01197092
Start Date
November 1 2010
End Date
January 1 2011
Last Update
November 16 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CFI Centrum für Integrative Medizin
Speyer, Germany, D-67346